Enzalutamide monotherapy: Extended follow-up of a phase II study in hormone-naive prostate cancer patients.
Bertrand Tombal
Consultant or Advisory Role - Amgen; Bayer; Ferring; Sanofi
Honoraria - Amgen; Bayer; Ferring; Sanofi
Michael Borre
No relevant relationships to disclose
Per Rathenborg
No relevant relationships to disclose
Patrick Werbrouck
No relevant relationships to disclose
Hendrik Van Poppel
No relevant relationships to disclose
Axel Heidenreich
No relevant relationships to disclose
Peter Iversen
Employment or Leadership Position - Astellas Pharma
Honoraria - Travel to advisory board meetings
Other Remuneration - Astellas Pharma
Johan Braeckman
No relevant relationships to disclose
Jiri Heracek
No relevant relationships to disclose
Edwina Baskin-Bey
Employment or Leadership Position - Astellas Pharma
Taoufik Ouatas
Employment or Leadership Position - Astellas Pharma
Frank Perabo
Employment or Leadership Position - Astellas Pharma
De Phung
Employment or Leadership Position - Astellas Pharma
Matthew R. Smith
Consultant or Advisory Role - Astellas Pharma; Janssen-Ortho